RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis

Breast Cancer Research

Volumn 12, Issue 5, 2010, Pages

  Cohn, Ellen ^a   Ossowski, Liliana ^a   Bertran, Silvina ^a   Marzan, Christine ^a   Farias, Eduardo F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; BETA1 INTEGRIN; CD24 ANTIGEN; CELL MARKER; MESSENGER RNA; RECEPTOR BLOCKING AGENT; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ALPHA 1; RETINOL; RO 41 5253; UNCLASSIFIED DRUG; WNT1 PROTEIN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; ISOENZYME; RETINAL DEHYDROGENASE; RETINOIC ACID RECEPTOR; WNT1 PROTEIN, MOUSE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; BREAST CARCINOGENESIS; BREAST DUCT; BREAST EPITHELIUM; BREAST TUMOR; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENETIC TRANSFECTION; KNOCKOUT MOUSE; MALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NEWBORN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH; ANIMAL; CELL TRANSFORMATION; CYTOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MORPHOGENESIS; MOUSE MUTANT; PHYSIOLOGY; TRANSPLANTATION; UDDER;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD29; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; ISOENZYMES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, KNOCKOUT; MORPHOGENESIS; RECEPTORS, RETINOIC ACID; RETINAL DEHYDROGENASE; SIGNAL TRANSDUCTION; STEM CELLS; WNT1 PROTEIN;

EID: 77957278179     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2724     Document Type: Article

References (57)

1. Wolbach SB, Howe PR. Nutrition Classics. The Journal of Experimental Medicine 42: 753-77, 1925. Tissue changes following deprivation of fat-soluble A vitamin. S. Burt Wolbach and Percy R. Howe. Nutr Rev 1978, 36:16-19. 10.1111/j.1753-4887.1978.tb03675.x, 342996.
2. Fitzgerald P, Teng M, Chandraratna RA, Heyman RA, Allegretto EA. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res 1997, 57:2642-2650.
3. Toma S, Isnardi L, Raffo P, Dastoli G, De Francisci E, Riccardi L, Palumbo R, Bollag W. Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction. Int J Cancer 1997, 70:619-627. 10.1002/(SICI)1097-0215(19970304)70:5<619::AID-IJC21>3.0.CO;2-6, 9052765.
4. Fontana JA, Hobbs PD, Dawson MI. Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. Exp Cell Biol 1988, 56:254-263.
5. Donato LJ, Noy N. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer Res 2005, 65:8193-8199. 10.1158/0008-5472.CAN-05-1177, 16166294.
6. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 1996, 16:1138-1149. 231096, 8622658.
7. Seewaldt VL, Kim JH, Caldwell LE, Johnson BS, Swisshelm K, Collins SJ. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ 1997, 8:631-641.
8. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976, 35:1332-1338.
9. Moon RC, Mehta RG. Chemoprevention of experimental carcinogenesis in animals. Prev Med 1989, 18:576-591. 10.1016/0091-7435(89)90031-5, 2694156.
10. Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, et al. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl 1994, 20:32-54. 10.1002/jcb.240560905, 7616752.
11. Clarke N, Germain P, Altucci L, Gronemeyer H. Retinoids: potential in cancer prevention and therapy. Expert Rev Mol Med 2004, 6:1-23. 10.1017/S1462399404008488, 15569396.
12. Fields AL, Soprano DR, Soprano KJ. Retinoids in biological control and cancer. J Cell Biochem 2007, 102:886-898. 10.1002/jcb.21530, 17902161.
13. Lotan R, Clifford JL. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed Pharmacother 1991, 45:145-156. 10.1016/0753-3322(91)90102-Y, 1657236.
14. Xu G, Redard M, Gabbiani G, Neuville P. Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol 1997, 151:1741-1749. 1858370, 9403724.
15. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira YLR. Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000, 92:475-480. 10.1093/jnci/92.6.475, 10716965.
16. Mendelsohn C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P, Mark M. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994, 120:2749-2771.
17. Mark M, Ghyselinck NB, Chambon P. Function of retinoic acid receptors during embryonic development. Nucl Recept Signal 2009, 7:e002. 2670431, 19381305.
18. Soprano DR, Teets BW, Soprano KJ. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm 2007, 75:69-95. full_text, 17368312.
19. Purton LE, Dworkin S, Olsen GH, Walkley CR, Fabb SA, Collins SJ, Chambon P. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 2006, 203:1283-1293. 10.1084/jem.20052105, 2121209, 16682494.
20. Li Y, Rosen JM. Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2005, 10:17-24. 10.1007/s10911-005-2537-2, 15886883.
21. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif 2003, 36(Suppl 1):59-72. 10.1046/j.1365-2184.36.s.1.6.x, 14521516.
22. Molyneux G, Regan J, Smalley MJ. Mammary stem cells and breast cancer. Cell Mol Life Sci 2007, 64:3248-3260. 10.1007/s00018-007-7391-5, 17955177.
23. Regan J, Smalley M. Prospective isolation and functional analysis of stem and differentiated cells from the mouse mammary gland. Stem Cell Rev 2007, 3:124-136. 10.1007/s12015-007-0017-3, 17873345.
24. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88. 10.1038/nature04372, 16397499.
25. Stingl J. Detection and analysis of mammary gland stem cells. J Pathol 2009, 217:229-241. 10.1002/path.2457, 19009588.
26. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
27. Lindeman GJ, Visvader JE, Smalley MJ, Eaves CJ. The future of mammary stem cell biology: the power of in vivo transplants. Breast Cancer Res 2008, 10:402. author reply 403, 10.1186/bcr1986, 2481484, 18522763.
28. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA 2003, 100:15853-15858. 10.1073/pnas.2136825100, 307657, 14668450.
29. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 2008, 26:364-371. 10.1634/stemcells.2007-0440, 17975224.
30. Liu BY, McDermott SP, Khwaja SS, Alexander CM. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci USA 2004, 101:4158-4163. 10.1073/pnas.0400699101, 384711, 15020770.
31. Lu Y, Bertran S, Samuels TA, Mira-y-Lopez R, Farias EF. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580. Oncogene 2010, 29:3665-3676. 10.1038/onc.2010.119, 20453882.
32. NIH Tools and Techniques in Mammary Gland Biology - Histological techniques. , http://mammary.nih.gov/tools/histological/Histology/index.html
33. Kupumbati TS, Cattoretti G, Marzan C, Farias EF, Taneja R, Mira-y-Lopez R. Dominant negative retinoic acid receptor initiates tumor formation in mice. Mol Cancer 2006, 5:12. 10.1186/1476-4598-5-12, 1444935, 16563162.
34. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 2006, 8:R7. 10.1186/bcr1371, 1413978, 16417656.
35. Rose-Hellekant TA, Gilchrist K, Sandgren EP. Strain background alters mammary gland lesion phenotype in transforming growth factor-alpha transgenic mice. Am J Pathol 2002, 161:1439-1447. 1867309, 12368216.
36. Davie SA, Maglione JE, Manner CK, Young D, Cardiff RD, MacLeod CL, Ellies LG. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res 2007, 16:193-201. 10.1007/s11248-006-9056-9, 1829418, 17206489.
37. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17:1253-1270. 10.1101/gad.1061803, 196056, 12756227.
38. Moraes RC, Zhang X, Harrington N, Fung JY, Wu MF, Hilsenbeck SG, Allred DC, Lewis MT. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 2007, 134:1231-1242. 10.1242/dev.02797, 17287253.
39. Asselin-Labat ML, Vaillant F, Shackleton M, Bouras T, Lindeman GJ, Visvader JE. Delineating the epithelial hierarchy in the mouse mammary gland. Cold Spring Harb Symp Quant Biol 2008, 73:469-478.
40. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567. 10.1016/j.stem.2007.08.014, 2423808, 18371393.
41. Li Y, Hively WP, Varmus HE. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 2000, 19:1002-1009. 10.1038/sj.onc.1203273, 10713683.
42. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008, 68:7711-7717. 10.1158/0008-5472.CAN-08-1949, 18829523.
43. Aupperlee MD, Smith KT, Kariagina A, Haslam SZ. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 2005, 146:3577-3588. 10.1210/en.2005-0346, 15878961.
44. Shyamala G, Yang X, Cardiff RD, Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci USA 2000, 97:3044-3049. 10.1073/pnas.97.7.3044, 16189, 10737785.
45. Satoh K, Hovey RC, Malewski T, Warri A, Goldhar AS, Ginsburg E, Saito K, Lydon JP, Vonderhaar BK. Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene 2007, 26:7526-7534. 10.1038/sj.onc.1210555, 17546050.
46. Watson CJ, Khaled WT. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 2008, 135:995-1003. 10.1242/dev.005439, 18296651.
47. Sternlicht MD. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 2006, 8:201. 10.1186/bcr1368, 1413974, 16524451.
48. Lu P, Sternlicht MD, Werb Z. Comparative mechanisms of branching morphogenesis in diverse systems. J Mammary Gland Biol Neoplasia 2006, 11:213-228. 10.1007/s10911-006-9027-z, 2577019, 17120154.
49. Wang YA, Shen K, Wang Y, Brooks SC. Retinoic acid signaling is required for proper morphogenesis of mammary gland. Dev Dyn 2005, 234:892-899. 10.1002/dvdy.20570, 16217742.
50. Easwaran V, Pishvaian M, Salimuddin, Byers S. Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 1999, 9:1415-1418. 10.1016/S0960-9822(00)80088-3, 10607566.
51. Shah S, Hecht A, Pestell R, Byers SW. Trans-repression of beta-catenin activity by nuclear receptors. J Biol Chem 2003, 278:48137-48145. 10.1074/jbc.M307154200, 12972427.
52. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009, 23:2563-2577. 10.1101/gad.1849509, 2779757, 19933147.
53. Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med 2000, 6:1235-1240. 10.1038/81335, 11062534.
54. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482. 10.1038/nature04703, 16598206.
55. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006, 441:518-522. 10.1038/nature04747, 16633340.
56. Dolle P. Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal 2009, 7:e006. 2686085, 19471585.
57. Prasad CP, Rath G, Mathur S, Bhatnagar D, Parshad R, Ralhan R. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer 2009, 9:325. 10.1186/1471-2407-9-325, 2753637, 19751508.